Literature DB >> 10778932

Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

T Kraemer1, G A Theis, A A Weber, H H Maurer.   

Abstract

Studies on the metabolism and the toxicological analysis of fenproporex (R,S-3-[(1-phenyl-2-propyl)-amino]-propionitrile, FP) using GC-MS and fluorescence polarization immunoassay are described. The metabolites were identified in urine samples of volunteers by GC-MS after cleavage of conjugates, extraction and acetylation. Besides unchanged FP, fourteen metabolites, including amphetamine, could be identified. Two partially overlapping metabolic pathways could be postulated: ring degradation by one- and two-fold aromatic hydroxylation followed by methylation and side chain degradation by N-dealkylation to amphetamine (AM). A minor pathway leads via beta-hydroxylation of AM to norephedrine. For GC-MS detection, the systematic toxicological analysis procedure including acid hydrolysis, extraction at pH 8-9 and acetylation was suitable (detection limits 50 ng/ml for FP and 100 ng/ml for AM). Excretion studies showed, that only AM but neither FP nor its specific metabolites were detectable 30-60 h after ingestion of 20 mg of FP. Therefore, misinterpretation can occur. The Abbott TDx FPIA amphetamine/methamphetamine II gave positive results up to 58 h. All the positive immunoassay results could be confirmed by the described GC-MS procedure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10778932     DOI: 10.1016/s0378-4347(99)00497-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.

Authors:  Camila S Model; Lara M Gomes; Giselli Scaini; Gabriela K Ferreira; Cinara L Gonçalves; Gislaine T Rezin; Amanda V Steckert; Samira S Valvassori; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-01-03       Impact factor: 3.584

2.  Imported fenproporex-based diet pills from Brazil: a report of two cases.

Authors:  Pieter A Cohen
Journal:  J Gen Intern Med       Date:  2009-03       Impact factor: 5.128

3.  Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.

Authors:  Gislaine T Rezin; Giselli Scaini; Gabriela K Ferreira; Mariane R Cardoso; Cinara L Gonçalves; Larissa S Constantino; Pedro F Deroza; Fernando V Ghedim; Samira S Valvassori; Wilson R Resende; João Quevedo; Alexandra I Zugno; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2012-07-27       Impact factor: 3.584

Review 4.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Effects of acute and chronic administration of fenproporex on DNA damage parameters in young and adult rats.

Authors:  Cinara L Gonçalves; Gislaine T Rezin; Gabriela K Ferreira; Isabela C Jeremias; Mariane R Cardoso; Samira S Valvassori; Bruna J P Munhoz; Gabriela D Borges; Bruno N Bristot; Daniela D Leffa; Vanessa M Andrade; João Quevedo; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2013-05-01       Impact factor: 3.396

Review 6.  Safety and efficacy of fenproporex for obesity treatment: a systematic review.

Authors:  Francisco José Roma Paumgartten; Sabrina Schaaf Teixeira Costa Pereira; Ana Cecilia Amado Xavier de Oliveira
Journal:  Rev Saude Publica       Date:  2016-05-24       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.